Pages that link to "Q29616827"
Jump to navigation
Jump to search
The following pages link to Fibroblast growth factor signalling: from development to cancer (Q29616827):
Displaying 50 items.
- Role and expression of FRS2 and FRS3 in prostate cancer (Q21261288) (← links)
- Cancer genome landscapes (Q22242276) (← links)
- New role for Kruppel-like factor 14 as a transcriptional activator involved in the generation of signaling lipids (Q24295074) (← links)
- Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function (Q24314826) (← links)
- Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties (Q24338659) (← links)
- Inhibition of basal FGF receptor signaling by dimeric Grb2 (Q24338779) (← links)
- Molecular biology of lung cancer (Q24606677) (← links)
- FGF signalling: diverse roles during early vertebrate embryogenesis (Q24630591) (← links)
- Blood vessel formation and function in bone (Q26739893) (← links)
- Safety of targeting tumor endothelial cell antigens (Q26748863) (← links)
- Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies? (Q26769611) (← links)
- Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis (Q26772984) (← links)
- Common stemness regulators of embryonic and cancer stem cells (Q26777882) (← links)
- Companion diagnostics for the targeted therapy of gastric cancer (Q26780298) (← links)
- Understanding Fibroblasts in Order to Comprehend the Osteopathic Treatment of the Fascia (Q26781823) (← links)
- Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis (Q26783169) (← links)
- Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population (Q26786594) (← links)
- Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1 (Q26798094) (← links)
- Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications (Q26801718) (← links)
- Programming and reprogramming a human heart cell (Q26823933) (← links)
- Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma (Q26824969) (← links)
- Compensatory angiogenesis and tumor refractoriness (Q26851916) (← links)
- Systemic and targeted therapies for early-stage lung cancer (Q26865490) (← links)
- The transcriptional regulation of pluripotency (Q26866571) (← links)
- Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors (Q26998790) (← links)
- Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer (Q27001260) (← links)
- The wound healing, chronic fibrosis, and cancer progression triad (Q27014616) (← links)
- Exploring mechanisms of FGF signalling through the lens of structural biology (Q27015054) (← links)
- Normal morphogenesis of epithelial tissues and progression of epithelial tumors (Q27015094) (← links)
- Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis (Q27026936) (← links)
- Fgf10 is required for specification of non-sensory regions of the cochlear epithelium. (Q27302948) (← links)
- Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation (Q27322795) (← links)
- Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy (Q27342077) (← links)
- A Novel Mode of Protein Kinase Inhibition Exploiting Hydrophobic Motifs of Autoinhibited Kinases: DISCOVERY OF ATP-INDEPENDENT INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR (Q27667388) (← links)
- FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures (Q27684227) (← links)
- The 1.65 Å resolution structure of the complex of AZD4547 with the kinase domain of FGFR1 displays exquisite molecular recognition (Q27698320) (← links)
- Design, synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold (Q27701029) (← links)
- Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. (Q27851615) (← links)
- Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer (Q27851654) (← links)
- Identification of targetable FGFR gene fusions in diverse cancers. (Q27852147) (← links)
- Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma (Q27852856) (← links)
- FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies. (Q27852999) (← links)
- Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis (Q27853061) (← links)
- FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers (Q27853171) (← links)
- Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations (Q27853244) (← links)
- FGFR1 is an adverse outcome indicator for luminal A breast cancers (Q27853294) (← links)
- The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine? (Q28074145) (← links)
- Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer (Q28077032) (← links)
- Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies (Q28079232) (← links)
- Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application (Q28079309) (← links)